Jinghua Peng

Key Laboratory Of Liver And Kidney Diseases
Shanghai, 201203, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Sanren Decoction Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease by Protecting Mitochondrial Function.

Sanren Decoction Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease by Protecting Mitochondrial Function.

Journal: Chinese journal of integrative medicine

Published: June 06, 2025

STING Activation in Various Cell Types in Metabolic Dysfunction-Associated Steatotic Liver Disease.

STING Activation in Various Cell Types in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: December 28, 2024

What is holding back preclinical GPR119 agonists from their potential as the therapeutics of type 2 diabetes?

What is holding back preclinical GPR119 agonists from their potential as the therapeutics of type 2 diabetes?

Journal: Expert opinion on therapeutic targets

Published: October 29, 2024

The Antiobesity Effects and Potential Mechanisms of Theaflavins.

The Antiobesity Effects and Potential Mechanisms of Theaflavins.

Journal: Journal of medicinal food

Published: December 07, 2023

Far-western Blotting Detection of the Binding of Insulin Receptor Substrate to the Insulin Receptor.

Far-western Blotting Detection of the Binding of Insulin Receptor Substrate to the Insulin Receptor.

Journal: Bio-protocol

Published: October 07, 2022

Inhibition on XBP1s-driven lipogenesis by Qushi Huayu Decoction contributes to amelioration of hepatic steatosis induced by fructose.

Inhibition on XBP1s-driven lipogenesis by Qushi Huayu Decoction contributes to amelioration of hepatic steatosis induced by fructose.

Journal: Journal of ethnopharmacology

Published: August 29, 2022

Hepatic transcriptome discloses the potential targets of Xuefu Zhuyu Decoction ameliorating non-alcoholic fatty liver disease induced by high-fat diet.

Hepatic transcriptome discloses the potential targets of Xuefu Zhuyu Decoction ameliorating non-alcoholic fatty liver disease induced by high-fat diet.

Journal: Journal of traditional and complementary medicine

Published: July 14, 2022

Activation of the canonical ER stress IRE1-XBP1 pathway by insulin regulates glucose and lipid metabolism.

Activation of the canonical ER stress IRE1-XBP1 pathway by insulin regulates glucose and lipid metabolism.

Journal: The Journal of biological chemistry

Published: May 06, 2022

Development and Functions of Mitochondria in Early Life.

Development and Functions of Mitochondria in Early Life.

Journal: Newborn (Clarksville, Md.)

Published: January 01, 2022

The P300 acetyltransferase inhibitor C646 promotes membrane translocation of insulin receptor protein substrate and interaction with the insulin receptor.

The P300 acetyltransferase inhibitor C646 promotes membrane translocation of insulin receptor protein substrate and interaction with the insulin receptor.

Journal: The Journal of biological chemistry

Published: October 25, 2021

Targeting the GPR119/incretin axis: a promising new therapy for metabolic-associated fatty liver disease.

Targeting the GPR119/incretin axis: a promising new therapy for metabolic-associated fatty liver disease.

Journal: Cellular & molecular biology letters

Published: June 07, 2021

Targeting programmed cell death in metabolic dysfunction-associated fatty liver disease (MAFLD): a promising new therapy.

Targeting programmed cell death in metabolic dysfunction-associated fatty liver disease (MAFLD): a promising new therapy.

Journal: Cellular & molecular biology letters

Published: November 02, 2020

Showing 1-12 of 32

Last Updated: 09/26/2026